lexiara

1.

Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance) · European Union

The Agency shall comprise: the Committee for Medicinal Products for Human Use, which shall be responsible for preparing the opinion of the Agency on any question relating to the evaluation of medicinal products for human use; the Committee for Medicinal Products for Veterinary Use, which shall be responsible for preparing the opinion of the Agency on any question relating to the evaluation of medicinal products for veterinary use; the Committee on Orphan Medicinal Products; the Committee on Herbal Medicinal Products; a Secretariat, which shall provide technical, scientific and administrative support for the committees and ensure appropriate coordination between them; an Executive Director, who shall exercise the responsibilities set out in Article 64; a Management Board, which shall exercise the responsibilities set out in Articles 65, 66 and 67.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-03 · Text as adopted (Official Journal); later amendments are not incorporated in this text.